A 65-year-old Hispanic male is referred to me for evaluation of erythrocyte sedimentation rate (ESR) > 100 mm/hour on several occasions. He has been followed by an ophthalmologist for severe diabetic ...

Temporal arteritis, now known as giant cell arteritis, is a form of vasculitis, or blood vessel inflammation. It involves a swelling and thickening of the lining of the artery under the skin on the ...

Giant cell arteritis (GCA) is the most common form of vasculitis in the older adult population. There are variable clinical presentations of this entity and no perfect diagnostic test, often making ...

KIAWAH ISLAND, S.C. — Temporal artery ultrasound and EULAR score are reliable means for diagnosing giant cell arteritis, Mercy Bechtold, MD, said during her presentation at Kiawah Eye. Ultrasound and ...

SHREVEPORT, La. - Giant cell arteritis, also known as temporal arteritis, is a less common condition where people get inflammation of the arteries that go to the head and neck. Symptoms include, head ...

Dear Dr. Roach: Your recent column featured polymyalgia rheumatica and prednisone. Would you please elaborate on how polymyalgia rheumatica can be linked to giant cell arteritis, and the consequences ...

SEVILLE, Spain — In this Healio Video Perspective, Andrew G. Lee, MD, discusses whether temporal artery ultrasound can be used in place of temporal artery biopsy in the diagnosis of giant cell ...

Giant-cell arteritis is a systemic vasculitis with limited treatment options. The efficacy and safety of upadacitinib — a selective Janus kinase (JAK) inhibitor that blocks the signaling of several ...

The FDA has approved AbbVie’s RINVOQ (upadacitinib) for the treatment of giant cell arteritis, making it the ninth approved indication for the drug. This also marks the first time an oral JAK ...

The US Food and Drug Administration (FDA) has granted approval for AbbVie’s 15mg Rinvoq (upadacitinib) to treat adults with giant cell arteritis (GCA). The approval follows the recent marketing ...